Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
26.03
+0.56 (2.20%)
At close: May 8, 2026, 4:00 PM EDT
26.09
+0.06 (0.23%)
After-hours: May 8, 2026, 4:49 PM EDT
Maze Therapeutics Employees
Maze Therapeutics had 141 employees as of December 31, 2025. The number of employees increased by 16 or 12.80% compared to the previous year.
Employees
141
Change (1Y)
16
Growth (1Y)
12.80%
Revenue / Employee
n/a
Profits / Employee
-$929,929
Market Cap
1.44B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 141 | 16 | 12.80% |
| Dec 31, 2024 | 125 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Immunocore Holdings | 524 |
| Wave Life Sciences | 317 |
| UroGen Pharma | 291 |
| KalVista Pharmaceuticals | 275 |
| Biohaven | 274 |
| Precigen | 160 |
| Bicara Therapeutics | 103 |
MAZE News
- 18 days ago - Maze Therapeutics priced offering of 5.54M shares of common stock at $23.50 - TheFly
- 18 days ago - Maze Therapeutics Announces $150 Million Registered Offering - GlobeNewsWire
- 26 days ago - Maze Therapeutics price target lowered to $64 from $68 at Truist - TheFly
- 5 weeks ago - Maze Therapeutics price target raised to $58 from $52 at JPMorgan - TheFly
- 6 weeks ago - MAZE Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 6 weeks ago - Maze Therapeutics falls -29.8% - TheFly
- 6 weeks ago - Maze Therapeutics share sell-off an ‘overreaction,’ says Raymond James - TheFly
- 6 weeks ago - Maze Therapeutics falls -33.2% - TheFly